Research in our group revolves around the evolution of antimicrobial resistance (AMR) in bacteria. We work on several aspects of this global health challenge.
Genomic Sequencing of Clinical Isolates: Collaborating with healthcare centers in India, we perform genomic surveillance of priority pathogens to understand the genetic roots of AMR, helping develop better diagnostics and predicting resistance spread.
Novel Analytical Approaches for AMR: Using cutting-edge computational methods, we analyze phenotypic surveillance data in innovative ways, uncovering valuable insights. Our approach even earned us an Innovation Award in the Global AMR Data Challenge 2023.
Experimental Evolution of Antibiotic Alternatives: We explore how bacteria evolve resistance to alternatives to antibiotics, providing insights into resistance potential and cross-resistance profiles using experimental evolution.